ATAI Life Sciences

ATAI Life Sciences

Yahoo Finance • 23 days ago

Why Eli Lilly Stock Climbed Today

What happened Shares of Eli Lilly(NYSE: LLY) rose on Monday after the U.S. Food and Drug Administration (FDA) approved the pharmaceutical giant's new diabetes treatment, tirzepatide. As of 1:50 p.m. ET, Eli Lilly's stock price was up more... Full story

Yahoo Finance • 26 days ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Key Takeaways; Cannabis Sector Vireo Growth to Acquire Planet 13 in Landmark All-Stock Deal SNDL Completed Parallel Asset Acquisition, Expanding its U.S. Medical Cannabis Footprint Tilray Posted Record FY2026 Revenue as Cannabis Sales Ros... Full story

Yahoo Finance • last month

ATAI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of AtaiBeckley to Eli Lilly

MONSEY, N.Y., July 28, 2026 (GLOBE NEWSWIRE) -- The Monsey law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of AtaiBeckley, Inc. (Nasdaq: ATAI) (“AtaiBeckley”) to Eli Lilly and Company (“Lilly”), pursuan... Full story

Yahoo Finance • last month

Cathie Wood's Ark Invest boosts stakes in Tesla, SpaceX, Meta, trimming Figma, Shopify

Cathie Wood’s ARK Invest’s largest purchase during July 20-24 was Tesla (TSLA [https://seekingalpha.com/symbol/TSLA]), with the firm acquiring an additional $52.7M stake after a steep sell-off post weaker-than-expected Q2 earnings report.... Full story

Yahoo Finance • last month

Cathie Wood Dumps $39 Million Worth of AMD Stock

This article first appeared on GuruFocus. Cathie Wood's ARK Invest reduced its position in Advanced Micro Devices (NASDAQ:AMD) during the week ended July 17, making the chipmaker its largest sale of the period. ARK sold approximately $39... Full story

Yahoo Finance • last month

AtaiBeckley (ATAI) After Eli Lillys Bid Still Looks Fully Valued

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Eli Lilly and Company has agreed to acquire AtaiBeckley (NasdaqGM:ATAI) in a cash and contingent v... Full story

Yahoo Finance • last month

Top Biotech Gainers: CDNA Soars On Medicare Policy, ATAI Acquired, ABT Lifts Outlook, APLM On Watch

(RTTNews) - Today's top gainers in the biotech space include CareDx, which rallied after Medicare finalized its Local Coverage Determination process for molecular testing of solid organ allograft rejection; AtaiBeckley, after agreeing to b... Full story

Yahoo Finance • last month

AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli Lilly

AtaiBeckley climbed to a new four-year high on Thursday, as investors bought into its shares following news that Eli Lilly agreed to acquire the company for up to $3.8 billion. In intra-day trading, the stock surged to a record high of $7... Full story

Yahoo Finance • last month

AtaiBeckley Soars as Eli Lilly Agrees to $2.8 Billion Buyout

This article first appeared on GuruFocus. taiBeckley (NASDAQ:ATAI), a New York-based developer of psychedelic-based treatments for mental health conditions, rose 34.70% premarket after Eli Lilly (NYSE:LLY) said it would acquire the compan... Full story

Yahoo Finance • last month

Stocks making the biggest moves midday: Manpower, Abbott, UnitedHealth, TSMC & more

Check out the companies making the biggest moves in midday trading: Abbott Laboratories – The maker of Ensure nutrition shakes jumped almost 11%. Abbott raised its full-year guidance for adjusted earnings, forecasting a range of $5.45 to $... Full story

Yahoo Finance • last month

Eli Lilly is acquiring psychedelic drug developer AtaiBeckley for $3.8 billion

Eli Lilly (LLY) is acquiring AtaiBeckley (ATAI) — a biopharmaceutical company that specializes in psychedelic-based mental health treatments — in a new deal valued at up to $3.8 billion. Mizuho Americas healthcare equity strategist Jared... Full story

Yahoo Finance • last month

Eli Lilly to buy psychedelic drugmaker AtaiBeckley for up to $3.8 billion in bet on depression therapy

What happened: AtaiBeckley (ATAI) stock jumped 30% pre-market Thursday after Eli Lilly (LLY) said it would acquire the clinical-stage biopharmaceutical company. What's behind the move: Eli Lilly is making a bet on neuroscience and psychia... Full story

Yahoo Finance • last month

Stocks making the biggest moves premarket: UnitedHealth, TSMC, GE Aerospace, J.B. Hunt & more

Check out the companies making the biggest moves in premarket trading: UnitedHealth — Shares rose more than 7% in early trading after the health insurance giant posted b etter-than-expected results for the second quarter. The company earne... Full story

Yahoo Finance • last month

AtaiBeckley jumps 30% as Eli Lilly agrees to buy psychedelic firm for up to $3.8B

[White, yellow, red, orange and blue pills on a purple cardboard background. Medication on a dark background with contrasting dramatic light.] Ivan Kovbasniuk/iStock via Getty Images Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) h... Full story

Yahoo Finance • last month

Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions

AtaiBeckley's lead program, BPL-003, is designed to provide durable relief from treatment-resistant depression Acquisition expands Lilly's neuroscience pipeline to address some of the most challenging conditions in mental health INDIANAP... Full story

Yahoo Finance • last month

Here Is Why AtaiBeckley (ATAI) Is One Of The 10 Best Stocks Under $10 That Could Triple

AtaiBeckley N.V. (NASDAQ:ATAI) is one of the 10 best stocks under $10 that could triple. On June 25, AtaiBeckley N.V. (NASDAQ:ATAI) shared that the company will be included in the Russell indices following their latest reconstitution. The... Full story

Yahoo Finance • last month

Top Biotech Gainers: NXTC Soars On Merger Deal, BMGL Moves Past Nasdaq Woes, OTLK Awaits FDA Verdict

(RTTNews) - Today's top gainers in the biotech space include NextCure, ahead of its planned merger with a private company that will create a newly branded public entity; Basel Medical, which recently regained Nasdaq compliance; and Outlook... Full story

Yahoo Finance • last month

The Race to Commercialize the World’s Most Powerful Psychedelic

An obscure psychedelic is drawing intense interest from the pharmaceutical industry. WSJ explores why companies are betting hundreds of millions of dollars on the therapeutic potential of a toad poison. View Comments... Full story

Yahoo Finance • 2 months ago

AtaiBeckley to join Russell 2000 and Russell 3000 indexes following annual reconstitution

AtaiBeckley to join Russell 2000 and Russell 3000 indexes following annual reconstitution Proactive uses images sourced from Shutterstock AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) announced on Thursday that it will be added to the Russell... Full story

Yahoo Finance • 3 months ago

Is AtaiBeckley Inc. (ATAI) the Hidden Penny Stock to Invest In?

AtaiBeckley Inc. (NASDAQ:ATAI) is among the hidden penny stocks to invest in. On June 8, H.C. Wainwright maintained a Buy rating on AtaiBeckley Inc. (NASDAQ:ATAI) with a price target of $25. With the highest 1-year price target among analy... Full story